NeuroTrainer for ADHD
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a VR-based cognitive training program called NeuroTrainer to determine its effectiveness in improving attention and executive function (thinking and planning skills) in students with ADHD. Participants will use the program in 30-minute sessions, three times a week for 12 weeks, engaging in game-like tasks that include physical activity. The program adapts to each student's performance level. Students aged 11-17 with ADHD who do not have severe depression or other major mental health issues might be a good fit. As an unphased trial, this study offers participants the chance to contribute to innovative research that could enhance cognitive training methods for ADHD.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that the NeuroTrainer intervention is safe for students with ADHD?
Research has shown that NeuroTrainer, a virtual reality (VR) tool, aims to improve focus, decision-making, and resilience. Athletes and students have used it, but its safety for people with ADHD remains unclear.
However, as a non-invasive VR program, NeuroTrainer is generally considered safe. Users engage in game-like tasks that adapt to their skill level, ensuring ease of use. No reports of serious side effects have emerged. For any concerns, consulting a healthcare provider may be beneficial.12345Why are researchers excited about this trial?
NeuroTrainer is unique because it uses a virtual reality (VR)-based cognitive training program to improve attention and executive function in students with ADHD. Unlike standard treatments like medication or behavioral therapy, NeuroTrainer combines game-like tasks with physical activity, making it a more engaging and interactive approach. Researchers are excited about its potential to adapt to each participant's performance level, offering a personalized experience that could enhance its effectiveness.
What evidence suggests that NeuroTrainer is effective for ADHD?
Research has shown that NeuroTrainer, a virtual reality-based program, holds promise for helping students with ADHD enhance their focus and thinking skills. In this trial, participants in the NeuroTrainer intervention arm will engage in VR-based cognitive training designed to boost mental control. Studies have found that this training improves results on tests measuring attention and flexibility, such as the Stroop test. Participants also performed better on tests assessing focus and attention to detail. Additionally, clear improvements in ADHD symptoms were observed after using the training. These findings suggest that NeuroTrainer could be a useful tool for improving focus and managing ADHD symptoms.36789
Who Is on the Research Team?
Jeff Nyquist, Ph.D.
Principal Investigator
NeuroTrainer
Are You a Good Fit for This Trial?
This trial is for students aged 11-17 who meet the diagnostic criteria for ADHD, regardless of severity. Participants should have an estimated IQ of 80 or higher and struggle with attention-related difficulties.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in NeuroTrainer VR-based cognitive training sessions, approximately three times a week for 12 weeks
Follow-up
Participants are monitored for changes in ADHD symptoms and academic performance
What Are the Treatments Tested in This Trial?
Interventions
- NeuroTrainer
Find a Clinic Near You
Who Is Running the Clinical Trial?
NeuroTrainer
Lead Sponsor
National Institute of Mental Health (NIMH)
Collaborator
University of California, Davis
Collaborator